Rho kinase inhibitors: potential treatments for diabetes and diabetic complications

H Zhou, Y Li - Current pharmaceutical design, 2012 - ingentaconnect.com
The small GTPase RhoA and its downstream effector, Rho kinase (ROCK), appear to
mediate numerous pathophysiological signals, including smooth muscle cell contraction …
被引用次数：38 相关文章

Rho kinase inhibitors: potential treatments for diabetes and diabetic complications

H Zhou, Y Li - Current pharmaceutical design, 2012 - pubmed.ncbi.nlm.nih.gov
The small GTPase RhoA and its downstream effector, Rho kinase (ROCK), appear to
mediate numerous pathophysiological signals, including smooth muscle cell contraction …

[引用][C] Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications

H Zhou, Y Li - Current Pharmaceutical Design, 2012 - hero.epa.gov
Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications | Health
& Environmental Research Online (HERO) | US EPA Jump to main content US EPA United …

Rho kinase inhibitors: potential treatments for diabetes and diabetic complications.

H Zhou, YJ Li - Current Pharmaceutical Design, 2012 - europepmc.org
The small GTPase RhoA and its downstream effector, Rho kinase (ROCK), appear to
mediate numerous pathophysiological signals, including smooth muscle cell contraction …

[引用][C] Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications

H ZHOU, YJ LI - Current pharmaceutical design (Print), 2012 - pascal-francis.inist.fr
Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

[引用][C] Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications

H ZHOU, YJ LI - Current pharmaceutical design, 2012 - Bentham